Search
 
Market Insights

5 new drugs coming down the pipeline in 2021

From prostate cancer to lymphoma, these drugs offer hope for consumers, but they come with hefty price tags.

X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Try of medical vialsAs the year progressed, the overall robust capabilities of the pharmacy industry and FDA regulators allowed drug development to remain at near-normal levels. (Image: Shutterstock)

Despite concerns about the effect of COVID-19 on the FDA’s work in approving new pharmaceutical treatments, 2020 did not see a major drop-off in approvals, according to a new report from OptumRx.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

Trending Stories

 

Recommended Stories

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.